Extra Space Storage, Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Extra Space Storage, Inc. trades at $146.41 (market cap $30.98B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.78B). The key difference: Extra Space Storage, Inc. is far larger — about 17.4× Recursion Pharmaceuticals Inc's market cap, and Extra Space Storage, Inc. pays a 4.42% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| EXR | RXRX | |
|---|---|---|
Market Cap | $30.98B | $1.78B |
Sector | Real Estate | Health |
52-Week High | $152.85 | $6.79 |
52-Week Low | $126.67 | $2.84 |
Enterprise Value | $44.70B | $1.30B |
Dividend Yield | 4.42% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RXRX trades at $3.22, up 1.26% today, with a neutral technical signal and bearish moving averages. The company reported a Q2 2026 EPS miss of -$0.25 versus -$0.24 expected, with revenue declining year-over-year. Financials show steep losses, including a net income margin of -961.97% in 2026, though cash flow from financing activities provides a runway through early 2028. Recent news highlights partnership progress with Genentech but notes competitive pressures and slow revenue growth.
Outlook remains speculative due to high cash burn and unproven commercial scalability, posing significant risk. Analyst consensus is mixed with 40% buy ratings, reflecting optimism for AI-driven drug discovery potential against persistent profitability challenges. Investment appeal hinges on pipeline milestones, but current fundamentals warrant caution.
Trailing returns across standard periods
Latest headlines on both assets
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →